S100A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.560150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.558000E-01
Normal-vs-Stage2
3.651400E-01
Normal-vs-Stage3
2.851600E-01
Normal-vs-Stage4
3.945200E-01
Stage1-vs-Stage2
6.124800E-01
Stage1-vs-Stage3
5.833000E-01
Stage1-vs-Stage4
1.306220E-01
Stage2-vs-Stage3
7.175600E-01
Stage2-vs-Stage4
5.757700E-02
Stage3-vs-Stage4
6.980500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.461600E-01
Normal-vs-AfricanAmerican
2.815000E-01
Normal-vs-Asian
4.475400E-01
Caucasian-vs-AfricanAmerican
3.052800E-01
Caucasian-vs-Asian
7.215600E-01
AfricanAmerican-vs-Asian
3.161600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.361600E-01
Normal-vs-Female
3.021000E-01
Male-vs-Female
9.004400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.596600E-01
Normal-vs-Age(41-60Yrs)
9.159600E-01
Normal-vs-Age(61-80Yrs)
1.300010E-01
Normal-vs-Age(81-100Yrs)
8.034600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.198200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.942400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.332400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.728410E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.729000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.767200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.186000E-01
Normal-vs-Daily Drinker
4.668600E-01
Normal-vs-Weekly Drinker
5.185200E-01
Normal-vs-Occasional Drinker
1.050770E-01
Normal-vs-Social Drinker
9.095600E-01
Non Drinker-vs-Daily Drinker
2.415600E-01
Non Drinker-vs-Weekly Drinker
4.583200E-01
Non Drinker-vs-Occasional Drinker
1.980770E-01
Non Drinker-vs-Social Drinker
2.962600E-01
Daily Drinker-vs-Weekly Drinker
4.100100E-02
Daily Drinker-vs-Occasional Drinker
2.449000E-01
Daily Drinker-vs-Social Drinker
4.741000E-01
Weekly Drinker-vs-Occasional Drinker
1.074160E-02
Weekly Drinker-vs-Social Drinker
1.957190E-01
Occasional Drinker-vs-Social Drinker
1.513230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.582000E-01
Normal-vs-Grade 2
6.271400E-01
Normal-vs-Grade 3
3.908600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.543160E-01
Grade 1-vs-Grade 3
1.345020E-01
Grade 1-vs-Grade 4
7.582000E-01
Grade 2-vs-Grade 3
4.090600E-01
Grade 2-vs-Grade 4
6.271400E-01
Grade 3-vs-Grade 4
3.908600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.480800E-01
Normal-vs-NonDiabetic
9.904500E-02
Diabetic-vs-NonDiabetic
8.131500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.917200E-01
Normal-vs-NoPancreatitis
1.942760E-01
Pancreatitis-vs-NoPancreatitis
1.055030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.353700E-02
Normal-vs-N1
8.594400E-01
N0-vs-N1
1.040440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.610400E-01
Normal-vs-TP53-NonMutant
2.049800E-01
TP53-Mutant-vs-TP53-NonMutant
1.209680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
